Most people are aware of the common uses for Botox: forehead lines, frown lines, and crow's feet. Other cosmetic uses include injections on the bridge of the nose for bunny lines, around the eyes to open up the eyes. In the lower face, injection sites include the edge of the nose to help lower the lips when people smile. This is particularly useful for people who show a lot of their gums above their teeth when they smile. At the same time, such injections decrease the depth of laugh lines. Injections in the chin can improve lines and bumps that occur in those areas. Injections just beside the chin can elevate the edge of the lips, leading to a less angry appearance.
Non-cosmetic uses for Botox include various areas for migraine headaches and in the underarms and palms for excessive sweating.
Distant spread of toxin effect
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botunilum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death. The risk of symptoms is probably greatest in children treated for spacticity, but symptoms can also occur in adults treated for spacticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spacticity in children and adults, cases of spread of effect have occured at doses comparable to those used to treat cervical dystonia at lower doses.
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botunilum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death. The risk of symptoms is probably greatest in children treated for spacticity, but symptoms can also occur in adults treated for spacticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spacticity in children and adults, cases of spread of effect have occured at doses comparable to those used to treat cervical dystonia at lower doses.
No comments:
Post a Comment